Consistent with the report that IL-33 could induce the activation of ERK1/2 in GC, we found that up-regulation of TTP decreased the phosphorylation of ERK1/2, implicating that TTP could suppress the expression of IL-33 and the activation of ERK1/2 at the same time. The gene discussed is MAPK3; the disease is gastric cancer.